Table 1.
The demographic and clinical details of both treatment groups.
| Variable | Group | P‐value | |||
|---|---|---|---|---|---|
| 1 (10 seconds/2 weeks) | 2 (20 seconds/4 weeks) | ||||
| N | (%) | N | (%) | ||
| Gender | 0.608 | ||||
| Male | 18 | 40 | 16 | 45.7 | |
| Female | 27 | 60 | 19 | 54.3 | |
| Age, mean (SD) | 25.8 (10.9) | 30.4 (14.5) | 0.107 | ||
| Number of warts, mean (SD) | 2.5 (2.2) | 2.4 (2.1) | 0.817 | ||
| Duration of warts in months, mean (SD) | 8.7 (10.8) | 12.4 (15) | 0.207 | ||
| Site of warts | 0.371 | ||||
| Hand | 36 | 80 | 24 | 68 | |
| Foot | 6 | 13.3 | 9 | 25.7 | |
| Both | 3 | 6.7 | 2 | 5.7 | |